Delpharm will manufacture BioNTech/Pfizer’s mRNA vaccine at its Saint-Rémy-sur-Avre site.
GSK agrees to sell its Poznań (Poland) manufacturing site to Delpharm.
A leading CDMO
Drug developer and Contract manufacturer. With its 17 plants, Delpharm is in the Top 5 CDMOs Worldwide.
Delpharm produces most dosage forms; non-sterile and sterile liquids, solids, semi-solids and biotech.
Development & Regulation
A team of experts to support new pharmaceutical products.
Management ownership 100%
World Top 5
SerializationMajor on going project for Delpharm since 2015, all Delpharm plants already shipping serialized products.
Regulatory affairsA full team dedicated to support you in the long term or for emergency needs.